Since IL-6 exposure increases the expression of c-Myc protein, down-regulates p53, and induces EMT [22], we wondered whether aspirin might counteract these IL-6-induced pro-tumorigenic effects in both cancer (HepG2) and non-cancerous (NCM460, MCF10A and MEF) cell lines. Here, TP53 is linked to cancer.